MedTrace Logo

In Vivo Proof-of-principle Study of Raman Spectroscopy in Trial Participants With Bladder Tumours

NCT05124106 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-12-13

No results posted yet for this study

Summary

The purpose with this clinical investigation is to perform Raman spectroscopy inside the vivid bladder and to acquire Raman spectra of normal and tumour bladder tissue, and in a post-processing step to determine the grade of the tumor.

Conditions

  • Endoscopic Bladder Cancer Diagnosis With Raman

Interventions

DIAGNOSTIC_TEST

Raman Spectrometry

Bladder tumor is examined with Raman spectrometry during endoscopy

Sponsors & Collaborators

  • Proff Dr Jürgen Popp, Leibniz Institute, IPHT, Jena, Germany

    collaborator UNKNOWN

  • Karin Mogensen urologist, Herlev hospital, Copenhagen, Denmark

    collaborator UNKNOWN

  • Proff Dr Iwan Schie, Leibniz Institute, IPHT, Jena, Germany

    collaborator UNKNOWN

  • University Hospital Bispebjerg and Frederiksberg

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-22
Primary Completion
2022-02-01
Completion
2022-04-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05124106 on ClinicalTrials.gov